1<p>table contains trends and significant results (in bold) of univariate and multivariate analysis of OS and PFS.</p>2<p>low is reference category and set as HR = 1.</p>3<p>only significant parameters from the univariate analyses of <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0076386#pone-0076386-t007" target="_blank">table 7</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0076386#pone-0076386-t008" target="_blank">8</a> were included in the multivariate analyses.</p
<p>Univariate and multivariate prognostic analysis of clinicopathological factors for OS in colorect...
<p>* Significant p-value</p><p><sup>a</sup> Marker expression in multivariate analyses adjusted for ...
<p><i>Abbreviations</i>: PFS = progression-free survival; OS = overall survival; HR = hazard ratio; ...
<p>OS, overall survival; DFS, disease-free survival; LRRFS, locoregional recurrence-free survival; D...
<p>*Significant <i>p-</i>values (<i>p</i><0.05) are in bold.</p><p>**<i>P-</i>value is calculated in...
1<p>table contains trends and significant results (in bold) of univariate and multivariate analysis ...
<p>Patient characteristics clinicopathological variables and their prognostic variables for BF, CF a...
<p>Bold items have been considered statistically significant. Multivariate analysis and Cox proporti...
<p>p53-AAbs: p53 autoantibodies; FIGO: International Federation of Gynaecology and Obstetrics; PLT: ...
Univariate and multivariate regression analyses examining clinical variables associated with PRTEE a...
a<p>Overall survival(OS).</p>b<p>Progression-free survival (PFS).</p><p>RR: relative risk.</p
<p>Variables with a P≤0.1 in univariate analysis were included in multivariate analysis, which was s...
<p>Univariate and Multivariate Analysis of Variables Associated with OS in Patients with gastric can...
<p>OS, overall survival; CI, confidential interval; HR, hazard ratio; *HR>1 indicates an increased r...
<p>Prognostic factors for OS and PFS as shown by univariate and multivariate analyses.</p
<p>Univariate and multivariate prognostic analysis of clinicopathological factors for OS in colorect...
<p>* Significant p-value</p><p><sup>a</sup> Marker expression in multivariate analyses adjusted for ...
<p><i>Abbreviations</i>: PFS = progression-free survival; OS = overall survival; HR = hazard ratio; ...
<p>OS, overall survival; DFS, disease-free survival; LRRFS, locoregional recurrence-free survival; D...
<p>*Significant <i>p-</i>values (<i>p</i><0.05) are in bold.</p><p>**<i>P-</i>value is calculated in...
1<p>table contains trends and significant results (in bold) of univariate and multivariate analysis ...
<p>Patient characteristics clinicopathological variables and their prognostic variables for BF, CF a...
<p>Bold items have been considered statistically significant. Multivariate analysis and Cox proporti...
<p>p53-AAbs: p53 autoantibodies; FIGO: International Federation of Gynaecology and Obstetrics; PLT: ...
Univariate and multivariate regression analyses examining clinical variables associated with PRTEE a...
a<p>Overall survival(OS).</p>b<p>Progression-free survival (PFS).</p><p>RR: relative risk.</p
<p>Variables with a P≤0.1 in univariate analysis were included in multivariate analysis, which was s...
<p>Univariate and Multivariate Analysis of Variables Associated with OS in Patients with gastric can...
<p>OS, overall survival; CI, confidential interval; HR, hazard ratio; *HR>1 indicates an increased r...
<p>Prognostic factors for OS and PFS as shown by univariate and multivariate analyses.</p
<p>Univariate and multivariate prognostic analysis of clinicopathological factors for OS in colorect...
<p>* Significant p-value</p><p><sup>a</sup> Marker expression in multivariate analyses adjusted for ...
<p><i>Abbreviations</i>: PFS = progression-free survival; OS = overall survival; HR = hazard ratio; ...